Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2
List of Figures 8
2 Introduction 10
2.1 What Is This Report About?
10
3 Definitions of Markets Covered in the Report 11
3.1 Diabetes Care
Devices 11
3.2 Glucose Monitoring Devices 11
3.2.1 Blood Glucose
Meters 11
3.2.2 Blood Glucose Strips 11
3.3 Insulin Delivery 11
3.3.1 Insulin Pens 11
3.3.2 Insulin Syringes 12
3.3.3 Insulin Pumps
12
3.3.4 Traditional Insulin Pump Accessories 12
4 Healthcare Sector
Review 13
4.1 Healthcare Expenditure 13
4.2 Healthcare Infrastructure
16
4.3 Healthcare Policy 18
4.3.1 Health Insurance Act 19
4.3.2
Healthcare Allowance Act 19
4.3.3 The Exceptional Medical Expenses Act
19
5 Regulation System 20
5.1 Medical Equipment Approval Process
20
5.1.1 Classification of Medical Devices 21
5.1.2 Conformity
Assessment Process 30
5.2 Post Market Surveillance (PMS) 33
6 Pricing
and Reimbursement 34
6.1 Pricing and Reimbursement in Netherlands 34
7
Distribution Structure 35
7.1 Distribution Structure in Netherlands 35
8 Diabetes Care Devices In Netherlands 36
8.1 Diabetes Care Devices, Cross
Country Comparison, Revenue ($ mn), 2000-2015 36
8.2 Diabetes Care
Devices, Netherlands, Overall Revenue ($ mn), 2000-2015 37
8.3 Diabetes
Care Devices, Netherlands, Category Volume (Units), 2000-2015 41
8.4
Diabetes Care Devices, Netherlands, Company Share (2007-2008) 44
9 Glucose
Monitoring In Netherlands 45
9.1 Glucose Monitoring Overall Revenue
(2000-2015) 45
9.1.1 Blood Glucose Meters Overall Revenue (2000-2015)
47
9.2 Glucose Monitoring Overall Volume (2000-2015) 49
9.2.1 Blood
Glucose Meters Overall Volume (2000-2015) 51
9.3 Glucose Monitoring
Average Price (2000-2015) 53
9.4 Glucose Monitoring Distribution Share
(2007-2008) 54
9.5 Glucose Monitoring, Netherlands, Company Share
(2007-2008) 55
10 Insulin Delivery In Netherlands 56
10.1 Insulin
Delivery Overall Revenue (2000-2015) 56
10.1.1 Insulin Pens Overall
Revenue (2000-2015) 58
10.2 Insulin Delivery Overall Volume (2000-2015)
60
10.2.1 Insulin Pens Overall Volume (2000-2015) 61
10.3 Insulin
Delivery Average Price (2000-2015) 63
10.4 Insulin Delivery Distribution
Share (2007-2008) 64
10.5 Insulin Delivery, Netherlands, Company Share
(2007-2008) 65
11 Overview of Key Companies in Netherlands Diabetes Care
Devices Market 66
11.1 F. Hoffmann-La Roche Ltd. 66
11.1.1 Company
Overview 66
11.1.2 Value Chain Analysis 67
11.1.3 F. Hoffmann-La Roche
Ltd Pipeline Products 69
11.2 LifeScan, Inc. 70
11.2.1 Company
Overview 70
11.2.2 LifeScan, Inc. Pipeline Products 70
11.3 Bayer
HealthCare AG 72
11.3.1 Company Overview 72
11.3.2 Value Chain
Analysis 73
11.3.3 Bayer HealthCare AG Pipeline Products 75
11.4
Abbott Laboratories 76
11.4.1 Company Overview 76
11.4.2 Value Chain
Analysis 77
11.4.3 Abbott Laboratories Pipeline Products 79
11.5 Novo
Nordisk A/S 81
11.5.1 Company Overview 81
11.5.2 Novo Nordisk A/S
Pipeline Products 81
11.6 Medtronic, Inc. 83
11.6.1 Company Overview
83
11.6.2 Value Chain Analysis 84
11.6.3 Medtronic, Inc. Pipeline
Products 86
11.7 ARKRAY, Inc. 94
11.7.1 Company Overview 94
11.7.2
ARKRAY, Inc. Pipeline Products 94
11.8 Becton, Dickinson and Company
96
11.8.1 Company Overview 96
11.8.2 Value Chain Analysis 96
11.9
Terumo Corporation 98
11.9.1 Company Overview 98
11.9.2 Value Chain
Analysis 98
11.10 Eli Lilly and Company 101
11.10.1 Company Overview
101
11.10.2 Value Chain Analysis 101
11.10.3 Eli Lilly and Company
Pipeline Products 104
11.11 Animas Corporation 105
11.11.1 Company
Overview 105
11.12 Sanofi-Aventis 105
11.12.1 Company Overview 105
11.13 Smiths Medical 105
11.13.1 Company Overview 105
11.13.2 Value
Chain Analysis 106
11.14 Diabetes Management International BV 108
11.14.1 Company Overview 108
12 Appendix 109
12.1 Global Markets
Direct Research Methodology 109
12.2 Coverage 110
12.3 Secondary
Research 110
12.4 Primary Research 111
12.5 Models 111
12.6
Forecasts 112
12.7 Expert Panel Validation 112
12.8 Currency
Conversion 113
12.9 Contact Us 114
12.10 Disclaimer 114
1.1 List of Tables
Table 1: Doctors by Specialty in Netherlands,
2000-2006 17
Table 2: Hospital Wards by Type in Netherlands, 2000-2006
18
Table 3: Diabetes Care Devices, Cross Country Comparison, Revenue
($ mn), 2000-2015 36
Table 4: Diabetes Care Devices, Netherlands,
Overall Revenue ($ mn), 2000-2015 37
Table 5: Diabetes Care Devices,
Netherlands, Cross-Category Analysis, 2000-2015 38
Table 6: Diabetes
Care Devices, Netherlands, Overall Revenue ($ mn), Historic, 2000-2008 39
Table 7: Diabetes Care Devices, Netherlands, Overall Revenue ($ mn),
Forecast, 2008-2015 40
Table 8: Diabetes Care Devices, Netherlands,
Category Volume (Units), 2000-2015 41
Table 9: Diabetes Care Devices,
Netherlands, Category Volume (Units), Historic, 2000-2008 42
Table 10:
Diabetes Care Devices, Netherlands, Category Volume (Units), Forecast,
2008-2015 43
Table 11: Diabetes Care Devices, Netherlands, Company
Share by Revenue ($ mn), 2007-2008 44
Table 12: Glucose Monitoring,
Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008 45
Table 13:
Glucose Monitoring, Netherlands, Revenue ($ mn) by Segment, Forecast,
2008-2015 46
Table 14: Blood Glucose Meters, Netherlands, Revenue ($
mn) by Sub-Segment, Historic, 2000-2008 47
Table 15: Blood Glucose
Meters, Netherlands, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 48
Table 16: Glucose Monitoring, Netherlands, Volume (Units) by Segment,
Historic, 2000-2008 49
Table 17: Glucose Monitoring, Netherlands,
Volume (Units) by Segment, Forecast, 2008-2015 50
Table 18: Blood
Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Historic,
2000-2008 51
Table 19: Blood Glucose Meters, Netherlands, Volume
(Units) by Sub-Segment, Forecast, 2008-2015 52
Table 20: Glucose
Monitoring, Netherlands, Average Price ($), Historic, 2000-2008 53
Table
21: Glucose Monitoring, Netherlands, Average Price ($), Forecast,
2008-2015 53
Table 22: Glucose Monitoring, Netherlands, Distribution
Share by Revenue ($mn), 2007-2008 54
Table 23: Glucose Monitoring,
Netherlands, Company Share by Revenue ($ mn), 2007-2008 55
Table 24:
Insulin Delivery, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008
56
Table 25: Insulin Delivery, Netherlands, Revenue ($ mn) by
Segment, Forecast, 2008-2015 57
Table 26: Insulin Pens, Netherlands,
Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 58
Table 27:
Insulin Pens, Netherlands, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
59
Table 28: Insulin Delivery, Netherlands, Volume (Units) by
Segment, Historic, 2000-2008 60
Table 29: Insulin Delivery,
Netherlands, Volume (Units) by Segment, Forecast, 2008-2015 60
Table 30:
Insulin Pens, Netherlands, Volume (Units) by Sub-Segment, Historic,
2000-2008 61
Table 31: Insulin Pens, Netherlands, Volume (Units) by
Sub-Segment, Forecast, 2008-2015 62
Table 32: Insulin Delivery,
Netherlands, Average Price ($), Historic, 2000-2008 63
Table 33:
Insulin Delivery, Netherlands, Average Price ($), Forecast, 2008-2015 63
Table 34: Insulin Delivery, Netherlands, Distribution Share by Revenue
($mn), 2007-2008 64
Table 35: Insulin Delivery, Netherlands, Company
Share by Revenue ($ mn), 2007-2008 65
Table 36: F. Hoffmann-La Roche
Ltd Pipeline Products by Equipment Type 69
Table 37: F. Hoffmann-La
Roche Ltd Pipeline Products by Development Stage 69
Table 38: F.
Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 69
Table 39:
LifeScan, Inc. Pipeline Products by Equipment Type 70
Table 40:
LifeScan, Inc. Pipeline Products by Development Stage 70
Table 41:
LifeScan, Inc. Pipeline Products by Therapy Area 70
Table 42:
LifeScan, Inc. Pipeline Products by Clinical Trials 71
Table 43:
LifeScan, Inc. Pipeline Products by News Summary 71
Table 44: Bayer
HealthCare AG Pipeline Products by Equipment Type 75
Table 45: Bayer
HealthCare AG Pipeline Products by Development Stage 75
Table 46:
Bayer HealthCare AG Pipeline Products by Therapy Area 75
Table 47:
Bayer HealthCare AG Pipeline Products by News Summary 75
Table 48:
Abbott Laboratories Pipeline Products by Equipment Type 79
Table 49:
Abbott Laboratories Pipeline Products by Development Stage 79
Table 50:
Abbott Laboratories Pipeline Products by Therapy Area 79
Table 51:
Abbott Laboratories Pipeline Products by Clinical Trials 80
Table 52:
Abbott Laboratories Pipeline Products by News Summary 80
Table 53:
Novo Nordisk A/S Pipeline Products by Equipment Type 81
Table 54:
Novo Nordisk A/S Pipeline Products By Development Stage 81
Table 55:
Novo Nordisk A/S Pipeline Products By Therapy Area 82
Table 56: Novo
Nordisk A/S Pipeline Products By Clinical Trials 82
Table 57:
Medtronic, Inc. Pipeline Products by Equipment Type 86
Table 58:
Medtronic, Inc. Pipeline Products By Development Stage 88
Table 59:
Medtronic, Inc. Pipeline Products By Therapy Area 90
Table 60:
Medtronic, Inc. Pipeline Products By Clinical Trials 92
Table 61:
Medtronic, Inc. Pipeline Products By News Summary 93
Table 62:
ARKRAY, Inc. Pipeline Products by Equipment Type 94
Table 63: ARKRAY,
Inc. Pipeline Products by Development Stage 94
Table 64: ARKRAY, Inc.
Pipeline Products by Clinical Trials 95
Table 65: ARKRAY, Inc.
Pipeline Products by News Summary 95
Table 66: Eli Lilly and Company
Pipeline Products by Equipment Type 104
Table 67: Eli Lilly and
Company Pipeline Products by Development Stage 104
Table 68: Eli
Lilly and Company Pipeline Products by Therapy Area 104
Table 69: Eli
Lilly and Company Pipeline Products by Clinical Trials 104
Table 70:
Eli Lilly and Company Pipeline Products by News Summary 104
Table 71:
USD to Local Currency, Average Exchange Rate 2008 113
1.2
List of Figures
Figure 1: Total Healthcare Expenditure in Netherlands,
2000 - 2006 14
Figure 2: Healthcare Financing Framework in Netherlands,
2005 15
Figure 3: Flowchart for Classification of Non-invasive Devices in
Netherlands, 2007 22
Figure 4: Flowchart for Classification of Invasive
Devices in Netherlands, 2007 23
Figure 5: Flowchart for Classification of
Invasive Devices in Netherlands, 2007 24
Figure 6: Flowchart for
Classification of Invasive Devices in Netherlands, 2007 25
Figure 7:
Flowchart for Classification of Invasive Devices in Netherlands, 2007 26
Figure 8: Flowchart for Classification of Active Devices in Netherlands, 2007
27
Figure 9: Flowchart for Classification of Active Devices in
Netherlands, 2007 28
Figure 10: Flowchart for Classification of Devices
except Non-invasive, Invasive and Active Devices in Netherlands, 2007 29
Figure 11: Conformity Assessment of Class-I Medical Devices in Netherlands,
2007 30
Figure 12: Conformity Assessment of Class-IIa Medical Devices in
Netherlands, 2007 31
Figure 13: Conformity Assessment of Class-IIb Medical
Devices in Netherlands, 2007 32
Figure 14: Conformity Assessment of
Class-III Medical Devices in Netherlands, 2007 33
Figure 15: Diabetes
Care Devices, Cross Country Comparison, Revenue ($ mn), 2000-2015 36
Figure 16: Diabetes Care Devices, Netherlands, Overall Revenue ($ mn),
2000-2015 37
Figure 17: Diabetes Care Devices, Netherlands,
Cross-Category Analysis, 2000-2015 38
Figure 18: Diabetes Care
Devices, Netherlands, Overall Revenue ($ mn), Historic, 2000-2008 39
Figure 19: Diabetes Care Devices, Netherlands, Overall Revenue ($ mn),
Forecast, 2008-2015 40
Figure 20: Diabetes Care Devices, Netherlands,
Category Volume (Units), 2000-2015 41
Figure 21: Diabetes Care
Devices, Netherlands, Category Volume (Units), Historic, 2000-2008 42
Figure 22: Diabetes Care Devices, Netherlands, Category Volume (Units),
Forecast, 2008-2015 43
Figure 23: Diabetes Care Devices, Netherlands,
Company Share (%), 2008 44
Figure 24: Glucose Monitoring,
Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008 45
Figure 25:
Glucose Monitoring, Netherlands, Revenue ($ mn) by Segment, Forecast,
2008-2015 46
Figure 26: Blood Glucose Meters, Netherlands, Revenue ($
mn) by Sub-Segment, Historic, 2000-2008 47
Figure 27: Blood Glucose
Meters, Netherlands, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 48
Figure 28: Glucose Monitoring, Netherlands, Volume (Units) by Segment,
Historic, 2000-2008 49
Figure 29: Glucose Monitoring, Netherlands,
Volume (Units) by Segment, Forecast, 2008-2015 50
Figure 30: Blood
Glucose Meters, Netherlands, Volume (Units) by Sub-Segment, Historic,
2000-2008 51
Figure 31: Blood Glucose Meters, Netherlands, Volume
(Units) by Sub-Segment, Forecast, 2008-2015 52
Figure 32: Glucose
Monitoring, Netherlands, Company Share (%), 2008 55
Figure 33:
Insulin Delivery, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008
56
Figure 34: Insulin Delivery, Netherlands, Revenue ($ mn) by
Segment, Forecast, 2008-2015 57
Figure 35: Insulin Pens, Netherlands,
Revenue ($ mn) by Sub-Segment, Historic, 2000-2008 58
Figure 36:
Insulin Pens, Netherlands, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015
59
Figure 37: Insulin Pens, Netherlands, Volume (Units) by
Sub-Segment, Historic, 2000-2008 61
Figure 38: Insulin Pens,
Netherlands, Volume (Units) by Sub-Segment, Forecast, 2008-2015 62
Figure
39: Insulin Delivery, Netherlands, Company Share (%), 2008 65
Figure
40: F. Hoffmann-La Roche Ltd Value Chain Analysis 67
Figure 41:
Bayer HealthCare AG Value Chain Analysis 73
Figure 42: Abbott
Laboratories Value Chain Analysis 77
Figure 43: Medtronic, Inc. Value
Chain Analysis 84
Figure 44: Becton, Dickinson and Company Value
Chain Analysis 96
Figure 45: Terumo Corporation Value Chain Analysis
98
Figure 46: Eli Lilly and Company Value Chain Analysis 101
Figure 47: Smiths Medical Value Chain Analysis 106
Figure 48:
Global Markets Direct Methodology 109
|
Related Report
|
View Cart
